SCHEMBL19981508

SCHEMBL19981508

CCOC(=O)/C=C/C(=O)Nc1nc(C)c(C)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.58
LMNA P02545 4/20 0.58
HTT P42858 1/20 0.58
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
KDM4E B2RXH2 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
POLB P06746 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 4/20 0.49
HPGD P15428 3/20 0.49
NPSR1 Q6W5P4 3/20 0.49
RAB9A P51151 3/20 0.49
MDM2 Q00987 1/20 0.48
PKM P14618 3/20 0.47
RXFP1 Q9HBX9 1/20 0.45
THRB P10828 1/20 0.44
NPC1 O15118 4/20 0.43
HSP90AA1 P07900 1/20 0.43
CCR6 P51684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974189 0.80 SMN1; SMN2 (0.56) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL19974188 0.80 SMN1; SMN2 (0.56) MAPTKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL19981509 0.80 ALDH1A1 (0.55) MAPTLMNAHTTKMT2AMEN1
SCHEMBL19981570 0.77 NPC1 (0.69) MAPTLMNAHTTKMT2AMEN1
SCHEMBL30271559 0.77 NPC1 (0.69) MAPTLMNAHTTKMT2AMEN1
SCHEMBL23647324 0.76 MAPT (0.64) MAPTLMNAHTTKMT2AMEN1
SCHEMBL19981418 0.76 MAPT (0.64) MAPTLMNAHTTKMT2AMEN1
SCHEMBL8918927 0.76 MAPT (0.57) MAPTSMN1; SMN2ALDH1A1HPGDRAB9A
SCHEMBL19974284 0.73 MAPT (1.00) MAPTLMNAHTTKMT2AMEN1
SCHEMBL19981479 0.73 LMNA (0.64) MAPTLMNAHTTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 MAPT 2930/4885LMNA 3549/4885HTT 1981/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 MAPT 2930/4885LMNA 3549/4885HTT 1981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.